Antimalarial drug susceptibility of Plasmodium vivax in the Republic of Korea.

Kesinee Chotivanich, Jetsumon Sattabongkot, Yien Kyong Choi, Jae Sun Park, Juntima Sritabal, Chae Seung Lim, Rachanee Udomsangpetch, Nicholas J White, Won Ja Lee
Author Information
  1. Kesinee Chotivanich: Faculty of Tropical Medicine, and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand.

Abstract

The antimalarial susceptibility of ring stage (> 80%) Plasmodium vivax from the Republic of Korea, where long incubation-period strains are prevalent, was evaluated using the schizont maturation inhibition technique. During 2005-2007, susceptibility to seven antimalarial drugs was evaluated with 24 fresh isolates. The geometric mean (95% confidence interval) 50% inhibition concentration (IC(50)) were quinine 60 (54-75) ng/mL, chloroquine 39 (22-282) ng/mL, piperaquine 27 (17-58) ng/mL, mefloquine 39 (35-67) ng/mL, pyrimethamine 138 (89-280) ng/mL, artesunate 0.6 (0.5-0.8) ng/mL, and primaquine 122 (98-232) ng/mL. Positive correlations were found between quinine and mefloquine (r = 0.6, P = 0.004), piperaquine and chloroquine (r = 0.6, P = 0.008), and piperaquine and primaquine IC(50) values (r = 0.5, P = 0.01). Compared with P. vivax in Thailand, P. vivax in the Republic of Korea was more sensitive to quinine and mefloquine, but equally sensitive to chloroquine and artesunate.

References

  1. Trans R Soc Trop Med Hyg. 1991 Jul-Aug;85(4):424-9 [PMID: 1836685]
  2. Am J Trop Med Hyg. 2005 Sep;73(3):604-8 [PMID: 16172490]
  3. Am J Trop Med Hyg. 1953 Nov;2(6):958-69 [PMID: 13104804]
  4. Am J Trop Med Hyg. 2007 Nov;77(5):947-54 [PMID: 17984359]
  5. Bull World Health Organ. 1975;52(1):21-32 [PMID: 764993]
  6. Clin Infect Dis. 2007 Apr 15;44(8):1067-74 [PMID: 17366451]
  7. Trans R Soc Trop Med Hyg. 2001 Nov-Dec;95(6):677-80 [PMID: 11816444]
  8. Clin Infect Dis. 1996 Nov;23(5):1171-3 [PMID: 8922821]
  9. Korean J Parasitol. 1999 Sep;37(3):129-43 [PMID: 10507220]
  10. Trans R Soc Trop Med Hyg. 1992 Mar-Apr;86(2):121-2 [PMID: 1440763]
  11. Trop Med Int Health. 2008 Jan;13(1):91-8 [PMID: 18291007]
  12. PLoS Med. 2008 Jun 17;5(6):e128 [PMID: 18563962]
  13. Trans R Soc Trop Med Hyg. 1999 Mar-Apr;93(2):165-8 [PMID: 10450440]
  14. Am J Trop Med Hyg. 2003 Apr;68(4):416-20 [PMID: 12875290]
  15. Trans R Soc Trop Med Hyg. 1976;70(5-6):474-81 [PMID: 320726]
  16. Korean J Parasitol. 2006 Dec;44(4):285-94 [PMID: 17170570]
  17. Trans R Soc Trop Med Hyg. 1995 May-Jun;89(3):307-8 [PMID: 7660445]
  18. Emerg Infect Dis. 1998 Apr-Jun;4(2):295-7 [PMID: 9621202]
  19. Korean J Parasitol. 2000 Sep;38(3):119-38 [PMID: 11002647]
  20. Am J Trop Med Hyg. 1991 May;44(5):547-52 [PMID: 1676566]
  21. Lancet. 1999 Aug 14;354(9178):546-9 [PMID: 10470698]
  22. Trop Med Int Health. 1996 Dec;1(6):816-9 [PMID: 8980595]
  23. Am J Trop Med Hyg. 2001 Aug;65(2):90-3 [PMID: 11508397]
  24. Am J Trop Med Hyg. 1953 Nov;2(6):970-6 [PMID: 13104805]
  25. Bull World Health Organ. 2006 Oct;84(10):827-34 [PMID: 17128363]
  26. Am J Trop Med Hyg. 2004 Apr;70(4):395-7 [PMID: 15100453]

Grants

  1. /Wellcome Trust
  2. 090207/Z/09/Z/Wellcome Trust

MeSH Term

Animals
Antimalarials
Drug Resistance
Humans
Inhibitory Concentration 50
Korea
Parasitic Sensitivity Tests
Plasmodium vivax

Chemicals

Antimalarials

Word Cloud

Created with Highcharts 10.0.00ng/mL=PvivaxsusceptibilityRepublicKoreaquininechloroquinepiperaquinemefloquine6rantimalarialPlasmodiumevaluatedinhibitionIC5039artesunateprimaquinesensitiveringstage>80%longincubation-periodstrainsprevalentusingschizontmaturationtechnique2005-2007sevendrugs24freshisolatesgeometricmean95%confidenceinterval50%concentration6054-7522-2822717-5835-67pyrimethamine13889-2805-0812298-232Positivecorrelationsfound004008values501ComparedThailandequallyAntimalarialdrug

Similar Articles

Cited By